Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Williams

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Leukemia Research|March 9, 2010
IL3 receptor-dependent therapeutic targeting of BCR-ABL-driven lymphoid leukemiasRichard T Williams
Nature Reviews. Cancer|June 25, 2008
BCR-ABL and CDKN2A: a dropped connectionRichard T Williams, Charles J Sherr
Advances in Experimental Medicine and Biology|August 19, 2007
The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaRichard T Williams, Charles J Sherr
Blood|September 18, 2009
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemiaEmmanuel J Volanakis, Richard T Williams, Charles J Sherr
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2006
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaRichard T Williams, Martine F Roussel, Charles J Sherr
Genes & Development|September 1, 2007
Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemiaRichard T Williams, Willem den Besten, Charles J Sherr
ACS Nano|May 14, 2020
Perovskite Quantum-Dot-in-Host for Detection of Ionizing RadiationRichard T Williams, Weronika W Wolszczak, Xiaoheng Yan, et al.
Journal of Combinatorial Chemistry|August 14, 2008
High throughput synthesis of polyesters using entropically driven ring-opening polymerizationsStephen D Kamau, Philip Hodge, Richard T Williams, et al.
Genes & Development|June 4, 2008
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABLCharles G Mullighan, Richard T Williams, James R Downing, et al.
Cell Cycle (Georgetown, Tex.)|October 6, 2005
Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor proteinWillem den Besten, Mei-Ling Kuo, Richard T Williams, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Leukemia Research|March 9, 2010
IL3 receptor-dependent therapeutic targeting of BCR-ABL-driven lymphoid leukemiasRichard T Williams
Nature Reviews. Cancer|June 25, 2008
BCR-ABL and CDKN2A: a dropped connectionRichard T Williams, Charles J Sherr
Advances in Experimental Medicine and Biology|August 19, 2007
The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaRichard T Williams, Charles J Sherr
Blood|September 18, 2009
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemiaEmmanuel J Volanakis, Richard T Williams, Charles J Sherr
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2006
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaRichard T Williams, Martine F Roussel, Charles J Sherr
Genes & Development|September 1, 2007
Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemiaRichard T Williams, Willem den Besten, Charles J Sherr
ACS Nano|May 14, 2020
Perovskite Quantum-Dot-in-Host for Detection of Ionizing RadiationRichard T Williams, Weronika W Wolszczak, Xiaoheng Yan, et al.
Journal of Combinatorial Chemistry|August 14, 2008
High throughput synthesis of polyesters using entropically driven ring-opening polymerizationsStephen D Kamau, Philip Hodge, Richard T Williams, et al.
Genes & Development|June 4, 2008
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABLCharles G Mullighan, Richard T Williams, James R Downing, et al.
Cell Cycle (Georgetown, Tex.)|October 6, 2005
Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor proteinWillem den Besten, Mei-Ling Kuo, Richard T Williams, et al.
Pageof 4